You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A Coriell Institute for Medical Research-led team is investigating influence of genetics on opioid addiction and abuse, WHYY reports.
An international team found 566 variants in 406 loci, 150 of which evidenced pleiotropic association for alcohol and tobacco use.
Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.
The designation will help the company accelerate the process of bringing the opioid addiction risk test through regulatory review and clearance.
CNN reports that researchers have tied a new variant to opioid addiction risk.
The guidelines are the first to attempt to specify which drugs are appropriate to test for routinely, guideline authors say.
Prescient Medicine says its genetic test can identify people who may be at a higher risk of developing an opioid addiction, Fast Company reports.
The university is marshaling the expertise across all its schools in studying myriad factors that might contribute to opioid response, addiction, and abuse.
The company joins others in a still-controversial setting, hoping to market its test to help guide the prescription of narcotic pain medications.
Proove Biosciences responds to its visit by federal investigators and concerns surrounding its tests and business approaches.
The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.
The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.
The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.
In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.